Aug 18, 2025 20:35
VOR - Vor Biopharma Inc. Common Stock
Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
---|---|---|---|---|---|---|---|
31.84 -1.07 (-3.36%) | --- | --- | 0.0 (0.0%) | 1.16 (3.64%) | -2.71 (-8.23%) | 0.45 (1.49%) | 0.45 (1.49%) |
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
Market Period:
Closed
Earnings & Ratios
- Basic EPS:
- -12.56
- Diluted EPS:
- -12.56
- Basic P/E:
- -2.4498
- Diluted P/E:
- -2.4498
- RSI(14) 1m:
- 0.0
- VWAP:
- 30.77
- RVol:
Events
Period | Kind | Movement | Occurred At |
---|
Related News
Jun 25, 2025 20:50
Jan 08, 2025 14:00
Dec 27, 2024 14:00
Sep 30, 2024 11:00
Sep 10, 2024 08:51
Jun 04, 2024 20:01
May 03, 2024 20:01
May 02, 2024 20:01
Apr 04, 2024 12:32